相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial
Guy F. A. Prado Jr et al.
REVISTA PORTUGUESA DE CARDIOLOGIA (2021)
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study)
Mario Iannaccone et al.
BMC CARDIOVASCULAR DISORDERS (2020)
One-Year Clinical Outcome of Inspiron Stent in All-Comers Population (Analysis from 790 Consecutive Patients)
Felipe Falcao et al.
JOURNAL OF INTERVENTIONAL CARDIOLOGY (2020)
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial
Juan F. Iglesias et al.
LANCET (2019)
Intravascular imaging comparison of two metallic limus-eluting stents abluminally coated with biodegradable polymers: IVUS and OCT results of the DESTINY trial
J. Ribamar Costa et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2017)
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial
David E. Kandzari et al.
LANCET (2017)
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial
Thomas Pilgrim et al.
LANCET (2014)
Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis
Eliano P. Navarese et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
Sripal Bangalore et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings
Kumaran Kolandaivelu et al.
CIRCULATION (2011)
A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions 12-Month Outcomes From the ENDEAVOR IV Trial
Martin B. Leon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease.
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
分享论文
